title: Screening of Microbial Extracts for Anticancer Compounds Using Streptomyces Kinase Inhibitor Assay.
abstract: Eukaryotic kinases are known to play an important role in signal transduction pathways by phosphorylating their respective substrates. Abnormal phosphorylations by these kinases have resulted in diseases. Hence inhibitors of kinases are of considerable pharmaceutical interest for a wide variety of disease targets, especially cancers. A number of reports have been published which indicate that eukaryotic-like kinases may complement two-component kinase systems in several bacteria. In Streptomyces sp. such kinases have been found to have a role in formation of aerial hyphae, spores, pigmentation & even in antibiotic production in some strains. Eukaryotic kinase inhibitors are seen to inhibit formation of aerial mycelia in Streptomyces without inhibiting vegetative mycelia. This property has been used to design an assay to screen for eukaryotic kinase inhibitors. The assay involves testing of compounds against Streptomyces 85E ATCC 55824 using agar well diffusion method. Inhibitors of kinases give rise to "bald" colonies where aerial mycelia and sporulation inhibition is seen. The assay has been standardized using known eukaryotic protein kinase inhibiting anticancer agents like AG-490, AG-1295, AG-1478, Flavopiridol and Imatinib as positive controls, at a concentration ranging from 10 μg/well to 100 μg/well. Anti-infective compounds which are not reported to inhibit eukaryotic protein kinases were used as negative controls. A number of microbial cultures have been screened for novel eukaryotic protein kinase inhibitors. Further these microbial extracts were tested in various cancer cell lines like Panel, HCT116, Calul, ACHN and H460 at a concentration of 10 μg/mL/ well. The anticancer data was seen correlating well with the Streptomyces kinase assay thus validating the assay.
authors.forename: Prashant
authors.initials: P
authors.lastname: Shanbhag
authors.forename: Sarita
authors.initials: S
authors.lastname: Bhave
authors.forename: Ashwini
authors.initials: A
authors.lastname: Vartak
authors.forename: Asha
authors.initials: A
authors.lastname: Kulkarni-Almeida
authors.forename: Girish
authors.initials: G
authors.lastname: Mahajan
authors.forename: Ivan
authors.initials: I
authors.lastname: Villanueva
authors.forename: Julian
authors.initials: J
authors.lastname: Davies
mesh_terms: D000970:Antineoplastic Agents / Q000032:analysis*; D004354:Drug Screening Assays, Antitumor / Q000379:methods*; D004791:Enzyme Inhibitors / Q000032:analysis*; D045325:HCT116 Cells; D006801:Humans; D010770:Phosphotransferases / Q000037:antagonists & inhibitors*; D013302:Streptomyces / Q000201:enzymology*
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D010770:Phosphotransferases